5Celli B R, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J]. Eur Respir J, 2004, 23(6):932-946.
6Richman-Eisenstat J B, Jorens P G, Hebert C A, et al. Interleukin-8: an important chemoattraetant in Sputum of patients with chronic inflammatory airway diseases [J]. Am JPhysiol, 1993, 26(4 Pt1): 413-418.
7Borchers M T, Garty M P, Leikauf G D. Regulation of human airway mucins by acrolein and inflammatory mediators [J]. Am JPhysiol, 1999, 276(4 Pt 1): 549-555.
8Mason K P, Zgleszewski S, Forman R E, et al. An exaggerated hypertensive response to glycopyrrolate therapy for bradycardia associated with high-dose dexmedetomidine [J]. AnesthAnalg, 2009, 108(3): 906-908.
9Rabe K F, Bateman E D, O'Donnell D D, et al. Roflumilast-anoral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial [J]. Lancet, 2005, 366(4985): 563-571.
10Bousquet J. Mometasone furoate: an effective anti- inflammatory with a well-defined safety and tolerability profile in the treatment of asthma [J]. Int J Clin Pract, 2009, 63(5): 806-819.
